lobbying_activities: 3488244

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3488244	c4607382-7ebc-41f7-8187-b18932b52395	Q4	MARSHALL & POPP, LLC	401105121	AMGEN USA INC.	2025	fourth_quarter	CPT	Issues related to intellectual property and patent reform, including: S.1040, Drug Competition Enhancement Act; S.1041, Affordable Prescriptions for Patients Act.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2026-01-16T10:40:37-05:00